FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?


BACKGROUND The aim of the study was to validate the association between the Arg166His polymorphisms of the Fc immunoglobulin receptor 2A (FCGR2A) and the Val212Phe of FCGR3A and pathological clinical response (pCR) to trastuzumab in HER2-positive breast cancer patients. METHODS Polymorphisms were characterized by pyrosequencing in 26 patients with ductal… (More)
DOI: 10.14740/wjon934w

1 Figure or Table


  • Presentations referencing similar topics